For the year ending 2025-12-31, ASBP has $1,312,166 in assets. $7,688,495 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 1,003,904 | |||
| Prepaid expenses and other current assets | 55,102 | |||
| Inventories | 253,160 | |||
| Total current assets | 1,312,166 | |||
| Total assets | 1,312,166 | |||
| Accounts payable | 1,014,377 | |||
| Accrued expenses | 1,008,569 | |||
| Other current liabilities-Affiliates | 353,679 | |||
| Notes payable related party-Related Party | 885,564 | |||
| Promissory note fee related party-Related Party | 1,000,000 | |||
| Derivative liability | 40,954 | |||
| Loan and transfer notes payable related party-Related Party | 499,214 | |||
| Subscription agreement loans | 1,500,000 | |||
| Convertible note | 1,290,476 | |||
| Total current liabilities | 7,592,833 | |||
| Forward purchase agreement liability | 95,662 | |||
| Total liabilities | 7,688,495 | |||
| Common stock 0.0001 par value 490,000,000 shares authorized 3,533,408 and 690,044 issued and outstanding at december 31, 2025 and 2024, respectively | 353 | |||
| Additional paid-in capital | 20,881,399 | |||
| Accumulated deficit | -27,258,081 | |||
| Total stockholders deficit | -6,376,329 | |||
| Total liabilities and stockholders deficit | 1,312,166 | |||
Aspire Biopharma Holdings, Inc. (ASBP)
Aspire Biopharma Holdings, Inc. (ASBP)